Dewpoint Therapeutics
Latest round
- Series C
Last raised
- Jan 2022
Total raised
- $286M
Investors
- 17
About Dewpoint Therapeutics
Dewpoint Therapeutics, Inc.Dewpoint Therapeutics, Inc. specializes in the development of therapies that target biomolecular condensates, fundamental to cellular organization and function. Founded in 2018, the company is headquartered in Boston, US. The CEO is Ameet Nathwani, with Richard Young as the founder. In September 2025, Dewpoint Therapeutics, Inc.Dewpoint Therapeutics specializes in the development of innovative therapies targeting biomolecular condensates, which are crucial for cellular organization and function. Their primary focus lies in crafting small molecule modulators aimed at addressing complex diseases associated with dysregulated condensates, including neurodegenerative conditions like ALS and various cancers such as colorectal, breast, and lung cancers. The company's product offerings aim to rescue cellular function and restore health by leveraging the unique properties of these condensates. Dewpoint collaborates with leading global pharmaceutical partners to enhance their therapeutic pipeline, which spans a range of diseases previously deemed undruggable.Dewpoint Therapeutics operates within a partnership-based revenue model, primarily generating funds through strategic alliances and collaborations with pharmaceutical companies. Revenue streams may include milestone payments and royalties from partnerships, particularly as the company advances its lead development candidates, such as DPTX3496, through clinical stages.In January 2022, Dewpoint Therapeutics, Inc. Dewpoint aims to expand into various geographies, specifically targeting new markets in North America and Europe, as they work towards launching new products focused on biomolecular condensates.
Who invested in Dewpoint Therapeutics
17 investors across 3 rounds
See all investors in Dewpoint Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Dewpoint Therapeutics
Who invested in Dewpoint Therapeutics?
Dewpoint Therapeutics has 17 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Dewpoint Therapeutics raised?
Dewpoint Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Dewpoint Therapeutics last raise money?
Dewpoint Therapeutics's most recent round on record is a Series C, in Jan 2022.
What does Dewpoint Therapeutics do?
Dewpoint Therapeutics is a pharmaceuticals company.
Where is Dewpoint Therapeutics headquartered?
Dewpoint Therapeutics is headquartered in Boston, US.
Which VCs invest in companies like Dewpoint Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Dewpoint Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Dewpoint Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.